Marijuana survey results set for discussion at INSA Springfield

31 Jul 2018 12:41 PM | Marion (Administrator)

Marijuana survey results set for discussion at INSA Springfield

By Mike Plaisance

Updated at 5:19 p.m. Tuesday, July 31, 2018 to note organizers changed the date of the unveiling of preliminary results from a national survey on marijuana use to Sept. 5 and said it will be held only in Springfield.

SPRINGFIELD -- Preliminary results of a national survey of marijuana use will be discussed at the INSA Springfield medical pot dispensary Sept. 5.

The Cannabis Community Care and Research Network (C3RN) of Somerville announced in June it was doing the survey with the University of Massachusetts in Dartmouth.

"With the cannabis industry finding its stride in Massachusetts, the lack of accessible, evidence-based information is a major roadblock in standardizing procedures for health and safety both at the state and national level," Dr. Marion McNabb, public health doctor and CEO of C3RN, said in a statement last week.

Presentations of survey results so far will be made at INSA Springfield at 506 Cottage St. here at a time to be determined. Organizers made changes from the original date of Aug. 15. Original plans also called for a presentation at INSA Easthampton but the event will be held only at the Springfield location, she said Tuesday. 

The survey is anonymous and takes less than 30 minutes, according to the survey website. The survey is available at

The survey's aim is to understand consumer/patient demographics, attitudes, choices, methods of consumption and knowledge of cannabis products in legal cannabis states, while also reducing the marijuana stigma, McNabb has said.

C3RN, a marijuana industry consultant and advocate, led a forum in Holyoke May 29 on marijuana's potential to replace opioids for pain relief.

Other medical marijuana facilities that C3RN is working with on the survey are BASK in Fairhaven and Revolutionary Clinics in Somerville and Cambridge. Also teaming up with C3RN on the project are medical doctors Dustin Sulak and Ryan Zaklin, the C3RN statement said.

The national survey is the first of many studies that C3RN is pursuing to add to the data on cannabis industry, McNabb said.

"We intend to highlight collective best practices that promote multi-sectoral collaboration between the cannabis industry, healthcare, academic, consumers and patient populations," she said.

The survey is scheduled to last through 2020, she has said.

Powered by Wild Apricot Membership Software